ICF Incorporated, L.L.C.
ICF Incorporated, L.L.C. is a global consulting and technology services company that provides a wide range of services to federal agencies through contract and grant awards. The company offers advisory, implementation, and program management services to government and commercial clients across domains including climate, energy, transportation, social programs, health, and disaster management. ICF has extensive experience supporting federal agencies through both prime contracts and subcontracts, delivering services such as program evaluation, technical assistance, environmental consulting, data analytics, and public health communications. With a diverse portfolio of federal work spanning numerous agencies and program areas, ICF demonstrates broad capabilities in addressing complex government challenges.
Through prime and subcontract awards, ICF has delivered a wide array of services to federal agencies. Key past contract awards have involved program evaluation and technical assistance services related to grant programs at USDA, HUD, DOE, and DOL. ICF has supported EPA, DOE, and NASA with environmental consulting, climate science, and energy analysis. At HHS and CDC, ICF has provided data analytics, statistical modeling, and public health communications. The company frequently serves as a prime contractor but has also teamed as a subcontractor on programs for DOD, USPTO, and USTDA. Contracts are a mix of set-aside and open awards under GWACs, IDIQs, MACs, and GSA Schedules. ICF's contract work demonstrates its ability to provide specialized expertise across multiple sectors of government operations.
On the grant side, ICF has secured prime awards as a recipient and subrecipient on projects across HUD's Indian Housing Block Grants program, HUD technical assistance and capacity building initiatives, and DOJ human trafficking victim services. Through these grants, ICF provides advisory services aligned with affordable housing, community development, and anti-trafficking programs. Grant work encompasses policy analysis, stakeholder outreach, and program management support. As a subrecipient, ICF has supported initiatives such as DOE's Industrial Assessment Centers program, substance use disorder services for the Commonwealth of Massachusetts, and USAID-funded climate change and economic growth projects. These grant activities showcase ICF's ability to collaborate with government agencies, academic institutions, and other partners to implement federally funded programs.
ICF holds a number of active indefinite delivery vehicles enabling it to streamline service delivery to federal clients. Under DOE's Energy Information Administration Omnibus Procurement V IDC, ICF provides survey operations, data modeling, and IT services supporting energy data collection and analysis. The company has multiple BPAs with agencies like EPA, FTA, and FHWA to provide technical support, research, and program management services. ICF also holds IDVs with HHS components for program evaluation, analytics, and technical assistance. These vehicles allow agencies to quickly access ICF's expertise across domains such as environmental management, transportation planning, public health, and social services. The breadth of ICF's IDV portfolio demonstrates its status as a trusted partner capable of supporting diverse federal agency missions through long-term contractual relationships.
QHBLBNKKV4U3 541611
Not listed 1902 Reston Metro Plaza, Reston, VA 20190, USA
1/7/02 1/28/26 Social & Scientific Systems, Inc.
Social & Scientific Systems, Inc., a subsidiary of DLH Holdings Corp., is a provider of health technology-enabled business process and program management solutions to federal agencies. The company specializes in epidemiology support, data management, IT infrastructure, and clinical research services for public health initiatives. With a long-standing history of supporting various agencies within the Department of Health and Human Services (HHS), including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Agency for Healthcare Research and Quality (AHRQ), Social & Scientific Systems has been registered to receive federal awards since May 2001. The company's expertise spans across multiple areas of public health research and program management, positioning it as a key partner in advancing federal health initiatives.
Through its federal contract awards, Social & Scientific Systems provides a wide range of services to support public health research and programs. These include epidemiology support, clinical research coordination, data management and analysis, statistical programming, and IT infrastructure maintenance. The company has received numerous task orders from NIH institutes such as the National Institute of Environmental Health Sciences (NIEHS), National Cancer Institute (NCI), and National Institute of Allergy and Infectious Diseases (NIAID). Notable projects include support for the Gene Therapy Resource Program, COVID-19 testing and research, and various epidemiological studies on topics such as radiation-related cancers and environmental factors affecting health. Social & Scientific Systems also provides access to Healthcare Cost and Utilization Project (HCUP) databases for agencies like CDC and AHRQ. The majority of these contracts are awarded without set-aside designations, and the company often collaborates with academic institutions and specialized subcontractors to deliver comprehensive research support.
Regarding federal grant awards, Social & Scientific Systems primarily acts as a subrecipient rather than a prime grantee. A notable subgrant award involves the company's participation in the National Dementia Workforce Study (NDWS), led by the University of Michigan. In this project, Social & Scientific Systems contributes to building a data infrastructure surrounding professional dementia workforce surveys, supporting research into the dementia care workforce and associated outcomes for persons living with dementia. This work aligns with the company's expertise in data management and analysis for public health research, demonstrating its ability to support large-scale, collaborative research initiatives in the field of healthcare workforce development.
Social & Scientific Systems holds several significant federal contract IDVs that enable various agencies to issue task orders for its services. A recent award from the HHS Administration for Community Living established a multiple-award IDIQ contract with a $75 million ceiling to support community living programs through 2029. The company also holds a single-award IDIQ from the NCI's Division of Cancer Epidemiology and Genetics, with a $320 million ceiling through 2027, to provide field and biospecimen support services. Additionally, Social & Scientific Systems has a Blanket Purchase Agreement with NIH's Office of Logistics and Acquisition Operations for marketing and professional services, with a $10 million ceiling. These IDVs demonstrate the company's capacity to provide long-term, comprehensive support across multiple areas of public health research and program management, allowing various HHS agencies to efficiently procure its services for a wide range of health-related initiatives.
XKMBEM2BTLK3 541715
Not listed 8757 Georgia Ave #1200, Silver Spring, MD 20910, USA
5/4/01 6/7/25 Westat, Inc.
Westat, Inc. is a prominent professional services firm that provides a wide range of research, technical assistance, and program support services to various federal agencies. Established in 1963 and headquartered in Rockville, Maryland, Westat specializes in survey research, data collection and analysis, program evaluation, and information technology solutions. The company has extensive experience working with government entities, particularly in areas such as public health, education, transportation, and social policy. Westat's federal contract and grant awards span numerous agencies, including the Department of Health and Human Services, Department of Education, National Science Foundation, and Department of Transportation, among others.
Through its federal contract awards, Westat has provided diverse services across multiple domains. For the National Cancer Institute, Westat has supported cancer clinical trials, offering services such as site study setup, protocol writing, and electronic patient-reported outcomes collection. The company has conducted national surveys for agencies like the National Highway Traffic Safety Administration, including occupant protection use surveys and booster seat usage studies. Westat has also provided data collection and analysis services for the Centers for Disease Control and Prevention, supporting programs such as the National Immunization Surveys. For the Food and Drug Administration, Westat has conducted studies on consumer perceptions of food labeling and medical device recalls. The company has also supported the Environmental Protection Agency with statistical analysis and technical support for various environmental health studies. These contracts demonstrate Westat's capabilities in large-scale data collection, analysis, and program evaluation across various public health and safety domains.
Westat's federal grant awards further showcase its expertise in research and evaluation services. The company has received grants from the National Institute of Justice to design and implement studies on interpersonal violence among young adults. For the National Institutes of Health, Westat has supported HIV/AIDS clinical trial networks and studies on maternal and child health. The company has also assisted the Bureau of Justice Statistics in conducting surveys on jails in Indian Country. Westat has collaborated with universities and research institutions on grants focused on topics such as sleep disparities, cognitive health, and substance abuse prevention. Additionally, the company has supported international health initiatives, such as population-based HIV impact assessment surveys in various countries. These grant-funded projects demonstrate Westat's ability to conduct complex, multi-year research studies and provide specialized data collection and analysis services in support of public health and social science research.
Westat holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, allowing for the issuance of task orders across a range of services. The company has a $320 million IDV with the National Cancer Institute for field and biospecimen support services, which includes study management, exposure assessment, and clinical support for cancer research. Westat also holds a $548 million IDV for the Cancer Trials Support Unit, providing broad-based support for cancer clinical trials. The Centers for Disease Control and Prevention awarded Westat a $310 million IDV for the National Immunization Surveys program, supporting vaccination coverage monitoring efforts. The company has a $175 million IDV with the National Institute of Child Health and Human Development for international and domestic pediatric HIV studies. Additionally, Westat holds IDVs with agencies such as the Substance Abuse and Mental Health Services Administration, the Administration for Community Living, and the Institute of Education Sciences, covering areas such as behavioral health research, aging and disability services, and education program evaluations. These IDVs demonstrate Westat's capacity to provide comprehensive, long-term support across various federal research and program evaluation initiatives.
NVUWAFWQ57S5 541720
Not listed 1600 Research Blvd, Rockville, MD 20850, USA
9/5/01 2/5/26 American Type Culture Collection
The American Type Culture Collection (ATCC) is a premier global biological materials and information resource and standards organization that collects, stores, and distributes standard reference microorganisms, cell lines, and other materials for research and development. It operates as a nonprofit biological resource center supporting government, academic, and industry customers.
ATCC has an extensive history of providing a wide range of biological products and services to federal agencies through prime and subcontract awards. Major activities include pathogen growth and storage, biospecimen processing, large-scale biomaterial manufacturing for vaccines and therapeutics, distributing critical reagents to infectious disease researchers through programs like BEI Resources, and aliquoting biosamples for medical research studies. ATCC has supported the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and other components of the Department of Health and Human Services, as well as the U.S. Department of Agriculture and Department of Defense. Contracts have involved both firm fixed-price and cost reimbursement pricing structures with and without set-aside designations. Key subcontractor partners have included Colorado State University, University of Texas Medical Branch, and Texas Biomedical Research Institute.
Through federal grant programs, ATCC has conducted research advancing the fundamental understanding of potential biothreat agents like alphaviruses, as well as supported infectious disease research through cooperative agreements with agencies like the National Institutes of Health and the Agricultural Research Service. Activities funded by grants range from studies on host-based therapeutic strategies to developing biological repositories of critical research materials. This work often complements ATCC's roles as a prime contractor by generating new scientific insights while building technical capabilities that enhance service delivery to federal agencies.
ATCC currently holds multiple federal indefinite delivery contract vehicles to provide centralized biological resource repositories as well as specialized capabilities spanning preclinical product development, field and biospecimen support services, and commercial-scale biomanufacturing. The Department of Health and Human Services has issued task orders against these contracts for medical countermeasures evaluation, storage and distribution of clinical trial specimens including select agents, preclinical studies to support vaccine and therapeutic development pipelines, and laboratory services like pathogen growth, characterization, and inventory management. Other federal agencies like the Centers for Disease Control and Prevention and Department of Agriculture have also issued task orders leveraging ATCC's technical expertise and infrastructure across the biological life cycle.
KT4MLLHK99V6 541715
Not listed 10801 University Blvd, Manassas, VA 20110, USA
3/11/02 7/30/25 Coriell Institute For Medical Research, Inc.
Coriell Institute For Medical Research, Inc. is an independent, non-profit biomedical research center dedicated to advancing scientific understanding of human diseases through genomics and cell biology. Founded in 1953, Coriell has established itself as a pioneer in genomics research and a leading provider of biorepository services to the federal government. The institute specializes in the collection, characterization, storage, and distribution of biological samples and associated data to support a wide range of biomedical research activities. Coriell's expertise spans areas such as genomics, cell culture, bioinformatics, and biospecimen management, making it a valuable partner for federal agencies engaged in cutting-edge genetic and biomedical research.
Coriell has been awarded several significant federal contracts to provide specialized biospecimen services. For the National Institute of Neurological Disorders and Stroke (NINDS), Coriell operates the NINDS Human Genetics Resource Center under an $11.2 million contract. This involves receiving, processing, storing, cataloging, and distributing biological samples and associated data to support research on neurological disorders. The institute also holds an $8.6 million contract with the National Institute on Aging for selection, production, characterization, and distribution of cultured cells for aging research. Additionally, Coriell was awarded a smaller $61,835 contract from the National Institute on Drug Abuse to produce reprogrammed iPSCs from patients with MPD5. These contracts are typically awarded without set-aside designations, reflecting Coriell's unique capabilities in biorepository management and cell culture services.
The institute's federal grant portfolio demonstrates its involvement in diverse areas of biomedical research. Coriell received a $246,324 grant from the National Science Foundation to investigate molecular differences between male and female mice during embryonic development, including gene expression and epigenetic features. The National Cancer Institute awarded Coriell a $10.4 million grant to study YAP1-mediated cancer stemness and immune suppression in gastric adenocarcinoma. The institute also participates in research on alcohol-induced metabolic reprogramming and esophageal pathology through a $2.5 million grant from the National Institute on Alcohol Abuse and Alcoholism. Coriell frequently collaborates with academic partners like the University of Texas MD Anderson Cancer Center, Temple University, and the University of California Santa Cruz on these research projects, often serving as a sub-awardee to provide specialized biospecimen services and genetic expertise.
Coriell Institute holds a significant Indefinite Delivery Contract (IDC) with the National Cancer Institute for Division of Cancer Epidemiology and Genetics Field and Biospecimen Support Services. This single-award IDC has a potential value of $320 million over five years. Under this contract, Coriell provides comprehensive field and biospecimen support services to assist in conducting epidemiological studies on cancer etiology and prevention. This includes recruiting and retaining study populations, collecting biospecimens and associated data, processing and storing samples, and coordinating logistics for fieldwork and specimen management. The contract allows the National Cancer Institute to obtain customized solutions for its evolving epidemiological research needs through task orders issued against this IDC vehicle. This large-scale contract underscores Coriell's unique position as a leading provider of biorepository and biospecimen services for federally-funded cancer research.
XQJNZNQZAFP3 541714
Not listed 403 Haddon Ave, Camden, NJ 08103, USA
9/21/01 9/26/25